retatrutide for autoimmune disease 🚀 may represent the next evolution in medical weight management by targeting three metabolic pathways simultaneously. While the results are exciting, proper medical supervision remains GLP-1 vs Retatrutide for Fat

A clinical trial for the pill showed that participants who took the full course of treatment over 64 weeks experienced an average weight loss of around 17%, compared to 3% weight loss in a placebo group

In 2021, the FDA approved Novo Nordisk's Wegovy, a slight reformulation of Ozempic designed specifically for weight loss, which drove a huge spike in public awareness of GLP-1 agonists

It works by supporting the skins natural repair process, helping to reduce the appearance of fine lines, redness, and uneven texture

Its not a direct fat burner, but it enhances fat metabolism when paired with movement and nutrition